Edition:
United States

Ascendis Health Ltd (ASCJ.J)

ASCJ.J on Johannesburg Stock Exchange

1,006.00ZAc
23 Apr 2018
Change (% chg)

0.00 (+0.00%)
Prev Close
1,006.00
Open
1,040.00
Day's High
1,040.00
Day's Low
985.00
Volume
248,753
Avg. Vol
734,509
52-wk High
2,600.00
52-wk Low
801.00

Chart for

About

Ascendis Health Limited is a health and care brands company. The Company operates through four segments: Consumer Brands, Pharma-Med, Phyto-Vet and International. Its Consumer Brands segment consists of health and personal care products sold to the public, primarily at the retail store level. It offers over the counter (OTC)... (more)

Overall

Beta: 0.97
Market Cap(Mil.): R4,979.51
Shares Outstanding(Mil.): 489.47
Dividend: 11.00
Yield (%): 2.29

Financials

  ASCJ.J Industry Sector
P/E (TTM): 10.49 30.21 32.78
EPS (TTM): 0.96 -- --
ROI: 3.88 13.61 13.21
ROE: 7.41 15.28 15.01

BRIEF-Ascendis Health HY HEPS Rises, Launches Strategic Review

* ‍DIRECTORS HAVE ELECTED NOT TO DECLARE AN INTERIM DIVIDEND AND TO RETAIN CASH TO SETTLE DEBT OBLIGATIONS​

Mar 01 2018

BRIEF-Ascendis Health appoints Thomas Thomsen as CEO with effect from 1 March 2018

* ANNOUNCE APPOINTMENT OF THOMAS THOMSEN AS CHIEF EXECUTIVE OFFICER AND AS AN EXECUTIVE DIRECTOR WITH EFFECT FROM 1 MARCH 2018

Feb 27 2018

BRIEF-Ascendis Health Sees ‍HY HEPS Of 52 - 55 Cents​

* SEES HY HEADLINE EARNINGS PER SHARE OF 52 - 55 CENTS​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Jan 31 2018

BRIEF-Ascendis Health announces acquisition of Kyron Laboratories Proprietary Ltd​

* ‍ACQUISITION OF 100% OF KYRON LABORATORIES PROPRIETARY LIMITED​

Nov 28 2017

BRIEF-Ascendis Health announces ‍transaction update relating to acquisition of Remedica​

* ‍TRANSACTION UPDATE RELATING TO ASCENDIS' ACQUISITION OF REMEDICA​

Nov 13 2017

BRIEF-Ascendis Health intends to raise about 750 mln rand in rights offering​

* ‍COMPANY INTENDS TO RAISE APPROXIMATELY 750 MILLION RAND IN RIGHTS OFFERING​

Nov 01 2017

Earnings vs. Estimates